← Leaderboards
Anne Church Hart
Massachusetts General Hospital
$8,456,760
Attributed
$8,927,500
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $923K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$8,927,500 · 8
By mechanism
R01$6,252,782 · 4
P01$1,470,705 · 1
R21$854,013 · 2
R43$350,000 · 1
Top collaborators
- Trisha Brock1 shared
- Christopher E Hopkins1 shared
- Alexander Jaworski1 shared
- Kathryn E Mccormick1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Ralph Weissleder$110,468,710
- Steven Kyle Grinspoon$75,757,679
- E. Antonio Chiocca$34,514,665
- Xandra Owens Breakefield$30,735,276
- Tayyaba Hasan$21,611,486
Others in their field
Top investigators on “Caenorhabditis Elegans”
- Paul Warren Sternberg · California Institute Of Technology$70,466,566
- Gary B. Ruvkun · Massachusetts General Hospital$34,445,663
- Monica A. Driscoll · Rutgers, The State Univ Of N.J.$28,359,225
- Robert H Waterston · Washington University$27,808,567
- Gordon J. Lithgow · Buck Institute For Age Research$27,627,681
- Albertha Johanna Walhout · Univ Of Massachusetts Med Sch Worcester$23,781,678
Research focus
Caenorhabditis ElegansGenesGeneticMolecularProteinsDefectPathway InteractionsDrosophila GenusPlayGenetic AnalysisInvertebratesBaseMutationAlzheimer&AposDementiaGenomeHomologous GeneNeuronsPathologyNotch ProteinS DiseaseCellsLigandsImmunohistochemistry
Grant awards (28)
Identification of conserved ALS-FTD suppressor genes$437,532
R21 · FY2021 · NS · contact PI
Examining cross-species suppression of neurodegeneration by loss of a conserved RNA binding protein in models of ALS and FTD$416,481
R21 · FY2021 · NS · contact PI
Testing Lifespan/Healthspan Pharmacological Interventions in Humanized C. elegans Knock-In Models of Dementia$350,000
R43 · FY2018 · AG
Genetic Analysis of SMN Pathways in C. elegans$278,338
P01 · FY2014 · NS · contact PI
Notch Functions in the Adult Nervous System$301,620
R01 · FY2013 · NS · contact PI
Genetic Analysis of SMN Pathways in C. elegans$276,732
P01 · FY2013 · NS · contact PI
Notch Functions in the Adult Nervous System$312,560
R01 · FY2012 · NS · contact PI
Genetic Analysis of SMN Pathways in C. elegans$292,506
P01 · FY2012 · NS · contact PI
Notch Functions in the Adult Nervous System$312,560
R01 · FY2011 · NS · contact PI
Genetic Analysis of SMN Pathways in C. elegans$298,357
P01 · FY2011 · NS · contact PI
Genetic Analysis of SMN Pathways in C. elegans$324,772
P01 · FY2010 · NS · contact PI
Notch Functions in the Adult Nervous System$315,667
R01 · FY2010 · NS · contact PI
Developmental analysis of SELCT proteins$282,596
R01 · FY2010 · GM · contact PI
Notch Functions in the Adult Nervous System$291,883
R01 · FY2009 · NS · contact PI
Developmental analysis of SELCT proteins$201,649
R01 · FY2009 · GM · contact PI
Developmental analysis of SELCT proteins$80,392
R01 · FY2009 · GM · contact PI
Notch Functions in the Adult Nervous System$55,930
R01 · FY2009 · NS · contact PI
Developmental analysis of SELCT proteins$299,250
R01 · FY2008 · GM · contact PI
Developmental analysis of SELCT proteins$299,250
R01 · FY2007 · GM · contact PI
C. ELEGANS MODEL FOR POLYGLUTAMINE TOXICITY$346,000
R01 · FY2005 · NS
C. ELEGANS MODEL FOR POLYGLUTAMINE TOXICITY$346,000
R01 · FY2004 · NS
MECHANOSENSATION AND OSMOSENSATION IN C ELEGANS$509,549
R01 · FY2003 · GM
C. ELEGANS MODEL FOR POLYGLUTAMINE TOXICITY$346,000
R01 · FY2003 · NS
MECHANOSENSATION AND OSMOSENSATION IN C ELEGANS$494,811
R01 · FY2002 · GM
C. ELEGANS MODEL FOR POLYGLUTAMINE TOXICITY$346,000
R01 · FY2002 · NS
MECHANOSENSATION AND OSMOSENSATION IN C ELEGANS$435,197
R01 · FY2001 · GM
C. ELEGANS MODEL FOR POLYGLUTAMINE TOXICITY$346,000
R01 · FY2001 · NS
MECHANOSENSATION AND OSMOSENSATION IN C ELEGANS$329,868
R01 · FY2000 · GM